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E-mail address: yuxycn@hotmail.com (X.-Y. Yu).Hsp60 is an important component of defense mechanisms against diabetic myocardial injury; how-
ever, the cause of Hsp60 reduction in the diabetic myocardium remains unknown. After stimulation
of cardiomyocytes with high glucose in vivo and in vitro, signiﬁcant up-regulation of miR-1/miR-206
and post-transcriptional modulation of Hsp 60 were observed. Serum response factor (SRF) and the
MEK1/2 pathway were involved in miR-1 and miR-206 expression in cardiomyocytes. miR-1 and
miR-206 regulated Hsp60 expression post-transcriptionally and accelerated cardiomyocyte apopto-
sis through Hsp60. These results revealed that miR-1 and miR-206 regulate Hsp60 expression, con-
tributing to high glucose-mediated apoptosis in cardiomyocytes.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
High glucose-induced apoptosis of cardiomyocytes contributes
to the development of diabetic complications [1,2]. Oxidative
stress and altered calcium homeostasis are involved in high glu-
cose-mediated cytotoxicity [3–5].
Heat shock proteins (Hsps) are a group of molecular chaperones
that are capable of preventing protein damage and proteolysis. Hsp
expression can be induced by heat, ischemia, hypoxia, ATP deple-
tion, free radicals, and hypothermia [6]. Whereas 75–85% of
Hsp60 is localized within the mitochondria, 15–20% is found in
the cytosolic compartment [7]. Hsp60 modulates the Bcl-2 family
of proteins, maintains the mitochondrial membrane electrochemi-
cal gradient, and prevents apoptotic cardiomyocyte death [6,8–10].
Thus, Hsp60 is an important component of defense mechanisms
against diabetic myocardial injury. However, Hsp60 expression is
signiﬁcantly reduced in the diabetic myocardium [11–14], and
the molecular mechanism for this reduction has yet to be
elucidated.
MicroRNAs (miRNAs) are endogenous 20–23-nucleotide (nt)-
containing small non-coding RNAs that negatively regulate genechemical Societies. Published by Eexpression in diverse biological and pathological processes, includ-
ing cell differentiation, proliferation, apoptosis, heart disease, neu-
rological disorders, and human cancers [15–19]. Recently, several
studies have demonstrated that dysregulation of miRNAs is linked
to diabetic cardiovascular dysfunction. For example, miR-221 is in-
volved in c-kit-mediated endothelial cell migration under hyper-
glycemic conditions [20]. In cardiomyocytes, the activity of
glucose transporter type 4 (GLUT4), the insulin-sensitive glucose
transporter, can be modulated by miR-133 and miR-223 [21,22].
Among the known miRNAs, miR-1 is speciﬁcally expressed in car-
diac and skeletal muscle cells [23–25]. Increased expression of
miR-1 was found in the ventricular samples from diabetic patients
[26]. In addition, high glucose-induced apoptosis of rat H9c2
cardiomyocytes via miR-1 and IGF-1 [27]. However, modulation
of Hsp60 expression by miRNAs in diabetic cardiomyocytes re-
mains to be determined.
In this study, we examined miR-1 and miR-206 expression in
rat myocardium after onset of hyperglycemia and rat neonatal
cardiomyocytes exposed to high glucose, and found that high glu-
cose-induced signiﬁcant up-regulation of miR-1 and miR-206. Fur-
thermore, serum response factor (SRF) and the MEK1/2 pathway
modulated miR-1 and miR-206 expression in cardiomyocytes.
We also validated that rat miR-1 and miR-206 negatively regulated
Hsp60 expression by directly targeting the 30 untranslated regionlsevier B.V. All rights reserved.
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expression, and up-regulation of miR-1 and miR-206 induced by
high glucose may increase cardiomyocyte apoptosis.
2. Materials and methods
2.1. Streptozotocin (STZ)-induced rat diabetes model
This study conformed to the Guide for the Care and Use of Lab-
oratory Animals published by the U.S. National Institutes of Health
(NIH publication number 85-23, revised 1996). Sprague–Dawley
(SD) rats weighing 245 ± 10 g (license number SCXK (YUE) 2004–
0011; Department of Experimental Animal Research Center, Sun
Yat-sen Medical College, Sun Yat-sen University, Guangzhou, Chi-
na) were used.
STZ (55 mg/kg body weight, i.p.) was injected consecutively on
alternate days into SD rats. The animals were fed a standard rodent
diet and received water ad libitum. Blood glucose levels were mon-
itored by tail-vein sampling. The diabetic rats were sacriﬁced at 4,
7, and 14 d after the onset of diabetes (random glucose >16.7 mM).
2.2. Echocardiography
Left ventricular (LV) function was assessed by transthoracic
echocardiography, which was carried out 4, 7, and 14 d after the
onset of diabetes. After administration of light general anesthesia,
the rats underwent transthoracic two-dimensional (2D) guided M-
mode echocardiography using a Technos MPX ultrasound system
(ESAOTE, Italy). From the cardiac short axis (papillary level), LV
end-diastolic dimension (LVDd), LV diameter at end-systole
(LVDs), and ejection fraction (EF) were measured. Echocardio-
graphic measurements included an average of at least three sepa-
rate cardiac cycles.
2.3. TUNEL assay
Terminal deoxynucleotidyl transferase-mediated dUTP-nick-
end labeling (TUNEL) was performed with a detection kit according
to the instructions of DeadEnd™ Fluorometric TUNEL System (Pro-
mega, Madison, WI, USA). Brieﬂy, heart tissue sections or H9C2
cells were ﬁxed with 4% methanol-free formaldehyde at 4 C for
25 min. Heart tissue sections were permeabilized with 20 lg/ml
Proteinase K; H9C2 cells were permeabilized with 0.2% Triton X-
100. After incubation with equilibration buffer (200 mM potassium
cacodylate, 25 mM Tris–HCl, 0.2 mM DTT, 0.25 mg/ml BSA, 2.5 mM
cobalt chloride, pH 6.6), DNA strand breaks in the apoptotic cells
were labeled with ﬂuorescein-12-dUTP. DAPI or Hoeshst was used
to stain the nuclei of all cells, and ﬂuorescence microscopy analysis
followed. The percentage of TUNEL-positive cells was determined
by counting approximately 200 cells per ﬁeld in ﬁve different
visual ﬁelds.
2.4. Construction of rat miR-1, miR-206, Hsp60 shRNA, and SRF shRNA
expression plasmids
Rat miR-1 and miR-206 DNA fragments were PCR-ampliﬁed
from SD rat genomic DNA after which they were introduced into
pcDNA3.1 (Invitrogen, Carlsbad, CA USA) to construct pcDNA3-
miR-1 and pcDNA3-miR-206 plasmids, respectively [28]. The tar-
get sequence of miR155-based rat Hsp60 shRNA corresponds to
the Hsp60 gene (GenBank Accession number: NM_022229)
sequence 50-AGGTGTGATGTTGGCTGTTGA-30, and the target
sequence of miR155-based rat SRF shRNA corresponds to the SRF
gene (GenBank Accession number: NM_001109302) sequence
50-GAAGATCAAGATGGAGTTCAT-30. Hsp60/miR155-shRNA and
SRF/miR155-shRNA expression cassettes were prepared and intro-duced into pcDNA3.1 vector to construct pcDNA3-Hsp60/miR155-
shRNA and pcDNA3-SRF/miR155-shRNA plasmids according to
our previous report, respectively [29].
2.5. Dual Luciferase assay for Hsp60 target identiﬁcation
Using the Targetscan program (www.targetscan.org/cgi-bin),
one region (50-AATAAAGACATTTGTACATTCCT-30), was predicted
to be the potential binding site of rat miR-1 and miR-206 in the
30-untranslated region of the rat Hsp60 gene. To anneal the dou-
ble-strand DNA containing the above region, the following two
oligonucleotides were synthesized: 50-CTAGATTGAATAAAGACAT
TTGTACATTCCTGATGCTGGGTGCAAGAGCCAG-30 and 50-AATTCTGG
CTCTTGCACCCAGCATCAGGAATGTACAAATGTCTTTATTCAAT-30. The
annealed double-stranded DNA fragment was introduced into the
Xba I and EcoR I sites (the additional EcoR I site was contained in
the engineered pGL3-promoter vector) at the 30 end of the ﬁreﬂy
luciferine gene in the pGL3-promoter vector (Promega) to
construct pGL3-Hsp60 bs. Using a site-directed mutagenesis kit
(TransGen, Beijing, China), the CATTC in the binding site for miR-
1/miR-206 in pGL3-Hsp60 bs was replaced with GTAAG to con-
struct pGL3-Hsp60-MUT bs.
Human embryonic kidney (HEK) 293 cells (3  105 cells per
well) were plated in 12-well plates 24 h before transfection. Cells
were co-transfected with 200 ng of pGL3- Hsp60 bs or pGL3-
Hsp60-MUT bs, 1 lg of pcDNA3-miR-1 or pcDNA3-miR-206, and
20 ng of pRL-TK (Promega). pRL-TK, which expresses Renilla lucif-
erase (RL) was added as an internal control for cell viability and
transfection efﬁciency. Activities of ﬁreﬂy luciferase and RL were
measured 48 h after transfection, and the relative ratio of the ﬁre-
ﬂy luciferase/RL was used to determine Hsp60 knock-down medi-
ated by miR-1 and miR-206.
2.6. Dual luciferase assay for miR-1 and miR-206 transcription activity
detections
The transcription factor, SRF, modulates miR-1 expression in
cardiomyocytes [30]. According to 60-kb 50UTR sequences of rno-
miR-1 (miRBase MI0003489, Chromosome 18: 2191,671-
2191,757) and rno-miR-206 (miRBase MI0000948, Chromosome
9: 19,401,985-19,402,068), three potential SRF recognition ele-
ments (REs) in 50UTR sequence of rno-miR-1 and ﬁve potential
SRF REs in 50UTR sequence of rno-miR-206 were identiﬁed. Oligo-
nucleotides were designed and synthesized to anneal to DNA con-
taining each SRF RE (Supplementary Table 1). The annealing DNA
fragments with sticky ends were inserted into the pGL3-enhancer
vector to construct recombinant luciferase reporter plasmids for
rno-miR-1 or rno-miR-206 transcription activity assays.
Rat H9c2 cardiomyocytes (3  105 cells per well) were plated in
12-well plates 24 h before transfection. Cells were co-transfected
with 1 lg of rno-miR-1 reporter plasmid or rno-miR-206 reporter
plasmid, and 20 ng of pRL-TK (Promega) was used as an internal
control for cell viability and transfection efﬁciency. Activities of
ﬁreﬂy luciferase and RL were measured 48 h after transfection
and incubation with 25 mM glucose in media; the relative ratio
of the ﬁreﬂy luciferase/RL was used for calculation of miR-1 or
miR-206 transcription activities.
2.7. Constructions of miR-1/miR-206 sponge expression plasmid
As an alternative to chemically-modiﬁed antisense oligonucleo-
tides, amiR-1/miR-206 sponge expression plasmidwas constructed
to block miR-1/miR-206 function. To construct the miR-1/miR-206
sponge expression plasmid, four repeats of the binding sequence
(50-AATAAAGACATTTGTACATTCCT-30) of rat miR-1 and miR-206
in the 30-untranslated region of the rat Hsp60 gene were tandemly
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EcoRI sites) of pcDNA3. The recombinant plasmid, pcDNA3-miR-1/
miR-206-sponge, was identiﬁed by DNA sequencing.
2.8. Cell culture and transfection
Neonatal rat ventricular cardiomyocytes (NRVCs) were isolated
from the hearts of new-born SD rats as described previously [31].
Isolated NRVCs were plated onto 12-well plates and maintained
for 48 h in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM)/F-12 sup-
plemented with 10% fetal bovine serum (FBS) (GIBCO, New York,
USA). The cells were serum-starved overnight prior to all experi-
ments. NRVCs were transfected with miR-1 mimics and/or miR-
206 mimics (Genpharma, Shanghai, China) using Oligofectamine
reagent (Invitrogen).Fig. 1. Analysis of miR-1 and miR-206 precursor transcripts and Hsp60 mRNA and pro
Hsp60 mRNA expression was detected using real-time quantitative PCR, and Hsp 60 p
precursors transcripts and Hsp 60 mRNA (A) and Hsp 60 protein (B) expression were dete
1 and mir-206 precursors transcripts and Hsp 60 mRNA (C) and Hsp 60 protein (D) expr
25 mM glucose for 12, 24, 48, and 72 h. Each value was expressed as the relative to the co
NRVCs were exposed to 25 mM glucose for 12, 24, 48 and 72 h after which caspase-9
control, #P < 0.01 versus control.H9c2 rat myoblasts were cultured in DMEM supplemented with
10% FBS at 37 C and 5% CO2. H9c2 cells were transfected with
pcDNA3, pcDNA3-miR-1, pcDNA3-miR-206, pcDNA3-miR-1/miR-
206-sponge, or pcDNA3-Hsp60/miR155-shRNA using Lipofect-
amine 2000 reagent (Invitrogen). After 48 h, Geneticin (G418)
(Invitrogen)was added to the culture medium at a concentration
of 600 lg/ml for screening and 300 lg/ml for ampliﬁcation of
transfected cells. pcDNA3 and pcDNA3-miR-1/miR-206-sponge
were also transfected into HEK293 cells to establish the corre-
sponding stable cell lines using the previously mentionedmethods.
2.9. Real-time quantitative PCR
Total cellular RNAs were extracted using Trizol reagent (Gibco-
BRL). First-strand cDNAs were synthesized using a mixture oftein and glucose-induced apoptosis. miR-1 and mir-206 precursors transcripts and
rotein expression was analyzed using Western blot analysis. miR-1 and mir-206
cted in diabetic rat hearts at 4, 7, and 14 d after streptozotocin (STZ) induction. miR-
ession were detected in neonatal rat ventricular cardiomyocytes (NRVC) exposed to
ntrol, and the value of control was set to 1. (E) Glucose-induced NRVC apoptosis. The
activities were assessed using a homogeneous luminescent assay. *P < 0.05 versus
Z.-X. Shan et al. / FEBS Letters 584 (2010) 3592–3600 3595oligo(dT)12–18 primers with Superscript reverse transcriptase
(Invitrogen). The real-time PCR was performed using the MJ Opti-
con II Quantitative PCR System (MJ Research, Waltham, MA, USA)
and the following thermal cycling proﬁle: 95 C for 5 min, followed
by 40 cycles of ampliﬁcation (94 C for 20 s, 58 C for 25 s, and
72 C for 25 s). The absorption values of the SYBR Green I ﬂuores-
cence in each tube were detected at the end of each cycle. The
housekeeping gene encoding b-actin was used as an internal con-
trol. The following speciﬁc primers were used in the real-time
PCR reaction: miR-1-forward, 50-TCAATCTCTAACAAGCTAATCTCT-
30 and miR-1-reverse, 50-TTGACAGTAGGTTAATCCAAAGT-30 (296
bp); miR-206-forward, 50-CAAGATGGCGACTTACGGATG-30 and
miR-206-reverse, 50-CTGCAGGTAGGACAAACGTG-30 (288 bp);
Hsp60-forward, 50-CTGCAATGACAATTGCTAAGAA-30 and Hsp60-re-
verse, 50-ATTCCAGGGTCCTTCTCTTCT-30 (250 bp); SRF-forward, 50-
CAGCCTCACCGTGCTCAATG-30 and SRF-reverse, 50-TCATTCACTCTT
GGTGCTGTG-30 (250 bp); and b-actin–forward, 50-GCCAACACAGTG
CTGTCTG-30 and b-actin-reverse, 50-TACTCCTGCTTGCTGATCCA-30
(203 bp). The relative expression values of miR-1 and miR-206
transcripts as well as HSP60 and SRF mRNAs were calculated using
2DDCt method [32].
2.10. Western blot analysis
The protein extract (30 lg) prepared from a tissue sample or
NRVC or H9c2 cells was separated by 12% SDS–PAGE and trans-
ferred to a polyvinylidene ﬂuoride (PVDF) membrane. The mem-
brane was blocked with 5% milk in Tris-buffer saline solution (pH
7.6) containing 0.05% Tween-20 (TBS/T), and incubated with high
afﬁnity antibody to Hsp60 (1:1000) (Santa Cruz, Santa Cruz, CA,
USA), or with high afﬁnity antibody to P-ERK1/2 (1:500), ERK1/2Fig. 2. miR-1 and miR-206 target Hsp60. The effect of miR-1 and miR-206 on Hsp60
was determined using the dual luciferase reporter system. The miRNA:mRNA
complementary sites between the mature sequences of miR-1 and miR-206 and the
30UTR of Hsp 60 gene are indicated. The matched base pairs are connected by a
vertical line, and the G:U/U:G wobble is indicated by dots. The GenBank accession
number for the Hsp 60 gene is indicated in brackets, and the mutated nucleotides in
the target sites are underlined. *P < 0.05 versus pGL3-promoter vector control.(1:500) (Cell Signaling Technology, MA, USA) overnight at 4 C.
The following day the membrane was incubated with horseradish
peroxidase (HRP)-conjugated secondary antibody (Santa Cruz) for
1 h at room temperature. The immunoreactive proteins were visu-
alized using ECL plus detection reagents (GE Healthcare, London,
UK). The membranes were immunoblotted with b-actin antibody
(1:1000) (Santa Cruz, USA) as an internal loading control.
2.11. Caspase-9 activity assay
The activity of caspase-9 was determined using a Caspase-9 As-
say Kit (Promega). NRVC and H9C2 cells were collected in lysis buf-
fer with proteasome inhibitor MG-132 (Promega) and used for
caspase-9 activity assay according to manufacturer’s instructions.
2.12. Quantiﬁcation of fragmented DNA in cell death by ELISA
DNA fragmentation in cell death was analyzed using a cell death
detection ELISA kit (Roche, Mannheim, Germany) according to the
manufacturer’s instructions. To determine the effect of glucose on
apoptosis, H9c2 cells in each groups were exposed to 25 mM glu-
cose for 72 h. After glucose exposure, cells were lysed in 100 lL
of lysis buffer and centrifuged for 10 min at 1500 rpm. DNA frag-
mentation was quantiﬁed by measuring absorbance at 405 nm
with a reference wavelength at 492 nm.
2.13. Statistical analysis
Data represent the mean ± standard deviation (S.D.). In each
experiment, all determinations were performed at least in tripli-
cate. Differences between the experimental groups were analyzed
using the Student0s t-test. A value of P < 0.05 indicated signiﬁcance.3. Results
3.1. Decreased heart function in STZ-induced SD rats
One week after STZ induction, rat body weight decreased signif-
icantly with high plasma glucose levels (random glucose
>16.7 mM; Data not shown). Echocardiography revealed that LVDd
and LVDs were signiﬁcantly increased, and EF was signiﬁcantly re-
duced 2 weeks after STZ induction (P < 0.05; Supplementary Table
2). Compared with the normal controls, apoptotic cardiomyocytes
signiﬁcantly increased 4 d after STZ induction and in a time-depen-
dent manner (Supplementary Fig. 1).
3.2. Up-regulation of miR-1 and miR-206 and down-regulation of
Hsp60 protein in diabetic hearts and high glucose-treated NRVCs
miR-1 and miR-206 precursors as well as Hsp60 mRNA and pro-
tein was observed in rat myocardium at 4, 7, and 14 d after STZ
induction. miR-1 and miR-206 expressions increased signiﬁcantly
in diabetic rat myocardium as compared to the normal control
(P < 0.05; Fig. 1A). Hsp60 mRNA levels did not change signiﬁcantly
in diabetic rat myocardium (Fig. 1A); however, Hsp60 protein de-
creased signiﬁcantly at 7 and 14 d after onset of hyperglycemia
(P < 0.05; Fig. 1B).
NRVCs were cultured and incubated with 25 mM glucose
in vitro. Quantitative PCR results showed that both miR-1 and
miR-206 were signiﬁcantly up-regulated in a time-dependent
manner in glucose-treated NRVCs (P < 0.05; Fig. 1C); Hsp60 mRNA
levels were not signiﬁcantly altered in response to glucose treat-
ment (Fig. 1C) as compared with normal control. Hsp60 protein de-
creased signiﬁcantly in glucose-treated NRVCs in a time-
dependent manner (P < 0.05; Fig. 1D). Furthermore, caspase-9
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cose for 72 h (P < 0.05; Fig. 1E).
3.3. Post-transcriptional repression of Hsp60 by miR-1 and miR-206
A bioinformatics-based approach was employed to predict the
putative targets using the TargetScan program hosted by the Well-
come Trust Sanger Institute [33]. One potential binding site was
found in the 30UTR of rat Hsp 60 gene for rat miR-1 and miR-206
(Fig. 2), and one similar potential binding site was found in theFig. 3. Effects of high glucose on miR-1 precursor transcript and Hsp60 expression and e
of miR-1 precursor transcript and Hsp 60 mRNA was examined by real-time quantitative
Hsp 60 protein expression was detected using Western blot analysis of the stable H9C2 ce
48 h. Each value was expressed as the ratio of caspase-9 activation to that observed in th
set to 1. (E) Glucose-induced H9C2 cell apoptosis. The stable H9C2 cells were exposed to
associated DNA fragments. Hsp 60 mRNA (F) and Hsp 60 protein (G) expression were dete
1 mimics plus 25 nM miR-206 mimics for 48 h. Each value was expressed as the relativ
internal control in the real-time quantitative PCR and Western blot analyses (A–C, F and G
in F and G) after incubation with 25 mM glucose for 48 h. Each value was expressed
transfected with Duplex control), and the value of control was set to 1. *P < 0.05 versus30UTR of human Hsp 60 gene for huamn miR-1 and miR-206 (Sup-
plementary Fig. 2). The dual luciferase assay demonstrated that
miR-1 and miR-206 signiﬁcantly reduced the luciferase activities
mediated by pGL3-Hsp60 bs (P < 0.05), but not pGL3-Hsp60-MUT
bs (Fig. 2).
The effects of miR-1 on Hsp60 expression in the stable H9C2
cells was also investigated. Whereas high glucose up-regulated
miR-1 precursor transcripts (P < 0.05; Fig. 3A), it did not alter
Hsp60 mRNA (Fig. 3B). Hsp60 mRNA was signiﬁcantly reduced
by Hsp60 shRNA, but was unaffected by over-expression offfects of miR-1 and miR-206 mimics on Hsp 60 expression. (A and B) The expression
PCR in the stable H9C2 cells with or without exposure to 25 mM glucose for 24 h. (C)
lls. (D) Caspase-9 activities in the stable H9C2 cells induced with 25 mM glucose for
e control group (H9C2 cells transfected with pcDNA3), and the value of control was
25 mM glucose for 72 h, and cells were assessed for apoptosis by analyzing histone-
cted in NRVCs transfected with 50 nM Duplex, 50 nMmiR-1 mimics and 25 nMmiR-
e to the Duplex control, and the value of control was set to 1. b-actin served as an
). (H) Caspase-9 activities in NRVCs transfected with corresponding mimics (shown
as the ratio of caspase-9 activation to that observed in the control group (NRVCs
control, #P < 0.01 versus control.
Fig. 3 (continued)
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that miR-1 does not affect Hsp60 mRNA stability. Consistent re-
sults were also observed in the miR-206-stable H9C2 cells (Data
not shown).
Western blot analysis revealed that miR-1 and miR-206 signif-
icantly reduced Hsp60 protein to an extent similar with Hsp60
shRNA (Fig. 3C, Supplementary Fig. 4A). In addition, miR-1/miR-
206-sponge could efﬁciently blocked miR-1 or miR-206 activity
(P < 0.01; Supplementary Fig. 3), and speciﬁcally reversed Hsp60
protein reduction mediated by miR-1 or miR-206 (Fig. 3C, Supple-
mentary Fig. 4A).
50 nMmiR-1 mimics and 25 nMmiR-1 mimics plus 25 nMmiR-
206 mimics could efﬁciently suppressed Hsp 60 protein expression
to the similar extent, without obvious effects on Hsp 60 mRNA
expression (P < 0.05; Fig. 3F and G).
3.4. miR-1 and miR-206 mediate their effects on H9c2 cell apoptosis
through Hsp60
Caspase-9 activities were signiﬁcantly increased in H9c2 cells
transfected with miR-1/miR-206 or Hsp60 shRNA after 48 h expo-
sure to 25 mM glucose (P < 0.05); no obvious elevations in caspase-
9 activities were observed in H9C2 cells transfected with miR-1/
miR-206-sponge (Fig. 3D, Supplementary Fig. 4B). Consistent re-
sults were observed in cell death ELISA assays of the stable H9c2
cells exposed to high glucose for 72 h (Fig. 3E, Supplementary
Fig. 4C). TUNEL assay also showed that the percentage of apoptotic
cells increased signiﬁcantly in high glucose-induced H9C2 cells
modiﬁed with miR-1 or Hsp60 shRNA (P < 0.05), and miR-1/miR-206 sponge speciﬁcally inhibited high glucose-induced H9c2 cell
apoptosis (Supplementary Fig. 5).
Caspase-9 activities were similarly and signiﬁcantly increased
in NRVCs transfected with 50 nM miR-1 mimics and in NRVCs
transfected with 25 nMmiR-1 mimics plus 25 nMmiR-206 mimics
after 48 h exposure to 25 mM glucose (P < 0.05; Fig. 3H).
3.5. The MEK1/2 pathway and SRF transcription factor mediate miR-1/
miR-206 expression in cardiomyocytes induced by glucose
SRF mRNA expression was observed in H9c2 cells after 12, 24,
36, and 72 h exposure to high glucose. Quantitative real-time
PCR showed that SRF mRNA was signiﬁcantly up-regulated by glu-
cose in a time-dependent manner (Supplementary Fig. 6).The Dual
luciferase assay revealed that three SRF REs in the 50UTR of rno-
miR-1 mediated miR-1 expression, and SRF RE2, RE3, RE4, and
RE5 mediated miR-206 expression in H9c2 cells induced with high
glucose (Fig. 4A). In addition, SRF shRNA efﬁciently inhibited miR-1
and miR-206 transcriptional activity (Data not shown) and reduced
their levels in H9c2 cells (P < 0.05; Fig. 4B). Quantitative real-time
PCR analysis revealed that the MEK1/2 inhibitor, PD98059, inhib-
ited miR-1 and miR-206 expression induced by glucose in H9c2
cells (P < 0.05; Fig. 4C). The activity of ERK1/2 was signiﬁcantly in-
creased in 25 mM glucose-treated NRVCs within 30–120 min, and
peak levels were observed at 60 min (Fig. 4D). IGF-1 (GroPep, Ade-
laide, Australia) at does of 15, 30 and 45 ng/ml could signiﬁcantly
inhibit mir-1 and miR-206 expression in a does-dependent manner
in 25 mM glucose-treated NRVCs for 24 h (Fig. 4E). In the presence
of 30 ng/ml IGF-1, mir-1 and miR-206 expression was signiﬁcantly
Fig. 4. The effects of SFR and IGF-1 on high glucose-induced miR-1 and miR-206 expression. (A) The luciferase activities in H9C2 cells transfected with eight different pGL3-
SRF-RE promoter plasmids and incubated with 25 mM glucose. Three potential SRF recognition elements (SRF-RE) were predicted in the 60 kb 50 UTR of the rat miR-1 and ﬁve
were predicted in the 60 kb 50 UTR of the rat miR-206 (schematic). H9C2 cells transfected with the pGL3-promoter were used as a control group. (B) The expression of miR-1
and miR-206 precursor transcripts were examined by real-time quantitative PCR in the SRF shRNA-transfected H9C2 cells incubated with 25 mM glucose for 24 h. H9C2 cells
transfected with pcDNA3 vector were used as the control group. (C) The expression of miR-1 and miR-206 precursor transcripts were examined by real-time quantitative PCR
in H9C2 cells incubated with 25 mM glucose and SB202190, SP600125, Wortmannin, or PD98059 for 24 h. H9C2 cells incubated with 25 mM glucose and DMSO were used as
the control group. (D) Analysis of time course of 25 mM glucose treatment on protein level of activated p-ERK1/2, with total ERK1/2 used as a control, in NRVCs. The
expression of miR-1 and miR-206 precursors was examined by real-time quantitative PCR in NRVCs with exposure to 25 mM glucose plus 0, 15, 30 and 45 ng/ml IGF-1 for
24 h (E), and in NRVCs with exposure to 25 mM glucose plus 30 ng/ml IGF-1 for 0, 6, 12 and 24 h, respectively (F). b-actin served as an internal control in the real-time
quantitative PCR assays in (B, E, and F). *P < 0.05 versus control, #P < 0.01 versus control.
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Fig. 5. miR-1/miR-206 regulate Hsp60 and IGF-1 expression, contributing to
glucose-mediated apoptosis in cardiomyocytes. A schematic diagram for the role
of miR-1 /miR-206 in Hsp 60 and IGF-1 reduction induced by high glucose is shown.
Up-regulation of miR-1/miR-206 by high glucose through the MEK1/2-SRF pathway
ERK1/2SRF results in suppression of Hsp 60 and IGF-1 expression and inhibition of
IGF-1/IGF-1R/PI3 K/Akt pathway, contributing to high glucose-mediated cardiomy-
ocyte apoptosis.
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(Fig. 4F).4. Discussion
We previously reported that high glucose promoted miR-1
expression in rat cardiac H9c2 cells [27]. In the present study,
miR-1 and miR-206 were up-regulated in the myocardium after
onset of hyperglycemia and in neonatal ventricular cardiomyo-
cytes and H9c2 cells after exposure to high glucose. This result is
also consistent with a previous study that reported increased
miR-1 expression in ventricular samples from diabetic patients
[26]. The present study showed increased apoptotic cardiomyo-
cytes in the diabetic myocardium in a time-dependent manner,
and cardiac function was decreased in STZ-induced SD rats with in-
creased apoptotic cardiomyocytes. Increased apoptosis was also
found in high glucose-treated cardiomyocytes in a time-dependent
manner. Because blocking miR-1 or miR-206 function using the
miR-1/miR-206 sponge inhibited cardiac cells apoptosis, up-regu-
lation of miR-1 and miR-206 may contribute to high glucose-in-
duced cardiac cell apoptosis. SRF was also up-regulated,
modulating miR-1 and miR-206 expression in cardiomyocytes ex-
posed to high glucose. This observation is consistent with a previ-
ous report that SRF regulates miR-1 expression during
cardiogenesis [30]. High glucose activated ERK1/2, and using the
MEK1/2 inhibitor, PD98059, could inhibit of both miR-1 and miR-
206 expression in cardiomyocytes exposed to high glucose. These
results indicate that blocking SRF or the MEK1/2 pathway may
present a novel method to inhibit miR-1 and miR-206 expression
in the diabetic myocardium.
Both miR-1 and miR-206 modulated Hsp60 expression in car-
diac cells post-transcriptionally, which is consistent with a report
that miR-1 suppresses Hsp60 expression in H9c2 cells under oxida-
tive stress [34]. However, no additive effects of miR-1 and miR-206
on Hsp 60 expression and cardiomyocyte apoptosis were found in
this study, the potential reason is that miR-1 and miR-206 share an
identical seed sequence to bind to the same site in the 30-UTR of
Hsp 60 mRNA (Fig. 2).Hsp60 is an anti-apoptotic protein, which can be constitutively
and inducibly expressed in mammalian tissues. Hsp60 can form
complexes with Bax, Bak, and Bcl-xS [7,9,10], preventing Bax olig-
omerization and insertion into the mitochondrial membrane, and
therefore avoiding the mitochondrial apoptotic pathway. In the
present study, we conﬁrmed that Hsp60 protein was reduced in
the diabetic myocardium as well as high glucose-treated cardio-
myocytes, which is consistent with previous reports [11–14]. In
addition, cell apoptosis levels were increased in the H9c2 cells
modiﬁed with Hsp60 shRNA, miR-1 or miR-206. Thus, miR-1 and
miR-206 regulate Hsp60 expression, thereby contributing to glu-
cose-mediated apoptosis in cardiomyocytes.
IGF-1 [27,35,36] and Hsp60 [7,9,10] protect the myocardium
against apoptosis through the mitochondrial pathway. Our previ-
ous study showed that IGF-1 could abrogate high glucose-induced
apoptosis of rat H9c2 cardiomyocytes and IGF-1 mediated the ef-
fect of miR-1 contributing to high glucose-induced H9c2 apoptosis
[27]. In the present study, we further demonstrated that IGF-1
could efﬁciently suppressed both miR-1 and miR-206 expression
in cardiomyocytes exposed to high glucose concentration. This re-
sult revealed that inhibiting miR-1 and miR-206 expression is a
new mechanism for the effect of IGF-1 in protecting cardiomyo-
cytes against high glucose-induced apoptosis.
Down-regulation of cytoplasmic Hsp60 contributes to IGF-1
receptor (IGF-1R) ubiquitination [14]. As predicted by the microR-
NA bioinformatics program (http://www.microrna.org), a potential
target site (6895–6916) in the 30-UTR of the human IGF1R gene
(GenBank accession, NM_000875) for human miR-1 and miR-206,
and a potential target site (5246–5267) in the 30-UTR of the mouse
IGF1R gene (GenBank accession, NM_010513) for mouse miR-1 and
miR-206 were found (data not shown). A recent study showed that
IGF-1R, phosphatidylinositol 30-kinase (PI3 K), and the protein ki-
nase B (Akt) were signiﬁcantly decreased in type 1-like diabetic
rats [37]. Therefore, the present ﬁndings suggest that up-regula-
tion of miR-1 and miR-206 contribute to high glucose-induced car-
diomyocyte apoptosis via two pathways. Firstly, miR-1 and miR-
206 suppress Hsp60 expression, and reduced Hsp60 contributes
to IGF1R degradation. Secondly, miR-1 and miR-206 inhibit IGF-
1/IGF-1R/PI3 K/AKt signaling pathway (Fig. 5).
In summary, the present study revealed a new pathway for
post-transcriptional control of Hsp60 in cardiomyocytes exposed
to high glucose. Speciﬁcally, high glucose stimulates miR-1 and
miR-206 expression through the MEK1/2 pathway and SRF, and
up-regulation of miR-1 and miR-206 suppress Hsp60 expression,
contributing to high glucose-mediated cardiomyocyte apoptosis.
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